What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - News Vall d'Hebron organizes the first international congress on the ERK5 protein in cancer The meeting allows establishing the basis for collaboration between experts from around the world, with the aim of promoting research on this protein and its role in cancer. Activities Lectura de Tesi "Desenvolupament de noves estratègies terapèutiques per a les distròfies musculars" Doctoranda: Penélope Romero Duque, Grup de Neurologia infantil del VHIR Directors: Dr. Jordi Barquinero i Dra. Francina Munell Tutor: Dr. Jose Aguilera Activities First International Meeting on ERK5 Signaling More information: https://aula.vallhebron.com/?go=info_cursos&curso=416&idioma=en Aula Vall d’Hebron Mail: inscripcionsaulavh@vhebron.net Tel: 93 489 45 68 News VHIR and Oncoheroes Biosciences to Partner for the Discovery and Development of Novel Therapies for Childhood Sarcomas In pediatric cancers, sarcomas account for 14% of cases and 20% of deaths. Activities Escola D'estiu Genètica Assistencial Més informació: https://aula.vallhebron.com/aula/?go=info_cursos&curso=425&idioma=ca Aula Vall d’Hebron Mail: inscripcionsaulavh@vhebron.net Tel: 93 489 45 68 News Catalan startup Manina Medtech creates a technology to increase the pregnancy ratio for in vitro reproduction Manina Medtech received a direct grant of 75,000 euros from the ACCIÓ Startup Capital line, aimed at boosting the growth of emerging companies with high technological potential. News Launch of the EUHA Innovation Network coordinated by Vall d’Hebron and Karolinska University Hospital On the 2nd and 3rd of June, the European University Hospital Alliance (EUHA) celebrated its 5th anniversary with a symposium at University Hospitals Leuven. News The Catalan government awards the Narcís Monturiol Plaque to the VHIR for its contribution to the development of science and technology This award is given to people and organisations in recognition of outstanding contributions to the development of science and technology in Catalonia. News New drug could improve response to cancer treatments The drug EB1, studied by researchers at Vall d'Hebron and IQS-Universitat Ramon Llull, is able to block resistance pathways to standard cancer treatments and could increase the efficacy of chemotherapy or immunotherapy. News New library of resources for translational medicine research on rare diseases The European Joint Programme on Rare Diseases (EJP RD) announces the release of the Innovation Management Toolbox (IMT), a tool created to provide self-help resources specific to the needs of researchers in this type of pathologies. News A VHIR study on the symptoms of persistent COVID funded by the Fundación Mutua Madrileña The research led by Dr. José Alegre has been one of the 21 projects selected in the 19th call for Health Research Grants. Activities Sessió Pediatria sobre el maneig del Lupus Eritematós Sistèmic Més informació: https://aula.vallhebron.com/aula/?go=info_cursos&curso=426&idioma=ca Aula Vall d’Hebron Mail: inscripcionsaulavh@vhebron.net Tel: 93 489 45 68 News VHIR Annual Report 2021 We present VHIR's annual commitment to communicate the scientific and institutional results of 2021 with a renewed format and design. News Ana Sánchez, investigadora del VHIR, guanya el concurs ‘Presenta la teva tesi en 4 minuts’ Ana Sánchez és investigadora predoctoral del grup Diagnostic Nanotools del VHIR i la seva tesi es centra en l’ús de cèl·lules sintètiques per millorar el control de pandèmies de grip. News L'Equip Multidisciplinari de Ginecologia de l'Hospital Vall d’Hebron, el primer de l'Estat en ser acreditat mundialment en Rec El protocol de Recuperació Intensificada en Cirurgia aconsegueix que el procés perioperatori de les pacients de ginecologia oncològica millori notablement, escurçant l'estada hospitalària, els reingressos, les complicacions postoperatòries i el confort de les pacients. News Identified one of the mechanisms that cause neuronal damage in patients with multiple sclerosis The research led by Vall d'Hebron is a breakthrough in the search for specific and effective treatments for the disease. News Pacients i professionals de Vall d’Hebron units per a la recerca del Parkinson La primera jornada dedicada a aquesta malaltia organitzada pel Campus Vall d’Hebron ha reunit més de 150 assistents. News The European Association of Pediatric Infectious Diseases has awarded a study in which Vall d'Hebron has participated The article on the mortality rate of young people with HIV due to perinatal transmission after transitioning to adult health care in Spain received the PIDJ award. News Identified a biomarker that predicts long-term impairment in progressive multiple sclerosis patients The study conducted at Vall d'Hebron shows that having a high level of neurofilament light chains translates, over the years, to a higher level of disability. News Apostem per la prevenció i la detecció precoç en el Dia Internacional del NASH Vall d'Hebron és referent en el diagnòstic i abordatge multidisciplinari de l’esteatohepatitis no alcohòlica i lidera el nombre d’assajos clínics a l’Estat sobre NASH. Pagination First page « Previous page ‹ … Page 42 Page 43 Current page 44 Page 45 Page 46 … Next page › Last page »
